The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 612.00
Bid: 612.00
Ask: 614.00
Change: -2.00 (-0.33%)
Spread: 2.00 (0.327%)
Open: 620.00
High: 620.00
Low: 612.00
Prev. Close: 614.00
PRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

29 Jun 2015 07:00

RNS Number : 4377R
Porvair PLC
29 June 2015
 

For immediate release 29 June 2015

 

Porvair plc

Half yearly results for the six months ended 31 May 2015

 

Porvair plc ("Porvair" or "the Group"), the specialist filtration and environmental technology group, today announces its half yearly results for the six months ended 31 May 2015.

 

Highlights

· Encouraging financial performance:

o As expected, revenue was lower at £46.3m (2014: £51.0m) due to the impact of large projects in the prior period.

o Lower revenue from large projects offset by 8% underlying growth1.

o Profit before tax up by 10% to £4.2m (2014: £3.8m).

o Earnings per share up 15% to 6.9 pence (2014: 6.0 pence).

o Net cash increased to £6.2m (31 May 2014: net debt of £1.0m; 30 November 2014: net cash of £5.3m).

· Microfiltration:

o Underlying revenues up 9%.

o Large contracts running smoothly including first contribution from CNOOC contract.

o Strong growth in the US - revenue up 44%.

o New facilities in UK and USA opened on schedule and budget.

o Order book healthy.

· Metals Filtration:

o Revenues up 6% (2% lower in constant currency) compared with a strong 2014.

o Superior performance of patented products continues to support growth.

o Acquisition in June of Fiber Ceramics will improve product capabilities and add capacity.

o New facility in China expected to be operational in the third quarter.

· Interim dividend increased over 8% to 1.3 pence (2014: 1.2 pence).

 

Commenting on the outlook, Ben Stocks, Chief Executive, said:

"Overall market demand is encouraging and order books continue to be healthy. We are winning market share with new products, notably in Metals Filtration and Seal Analytical. The Group has a strong balance sheet, a promising project pipeline and has made a good start to 2015."

Note 1. Underlying growth: Revenue growth excluding the impact of large projects.

 

For further information please contact:

Porvair plc

 

0207 466 5000

today

Ben Stocks, Chief Executive

 

01553 765 500

thereafter

Chris Tyler, Group Finance Director

 

 

 

Buchanan Communications

 

0207 466 5000

 

Charles Ryland / Stephanie Watson

 

 

 

 

A copy of the presentation that accompanies these results is available at www.porvair.com 

Operating Review

 

Overview

Profit before tax for the six months ended 31 May 2015 was up 10% to £4.2m (2014: £3.8m). Earnings per share grew 15% to 6.9p (2014: 6.0p). Cash generation was strong again with the Group holding a net cash balance of £6.2m (31 May 2014: net debt of £1.0m) at the end of the period, £7.2m higher than the previous year.

As anticipated in previous statements, revenue at £46.3m (2014: £51.0m) was £4.7m lower than the prior year due to revenue from large projects being £8.1m lower than in the first half of 2014. Underlying growth was 8% reflecting encouraging progress against financial and strategic targets.

The second half of 2015 has started well and order books are healthy, notably in Seal Analytical which is having a good year.

Progress towards key operating objectives in the period include:

· Large projects running to plan;

· Expanded facilities attracting new customers;

· New products introduced in both Seal Analytical and Selee Corp; and

· A promising pipeline of future work.

Strategic statement

Porvair's strategy has remained consistent for a number of years. It is to generate shareholder value through the development of specialist filtration and environmental technology businesses, both organically and by acquisition. Such businesses have certain key characteristics in common:

· specialist design or engineering skills are required;

· product use and replacement is mandated by regulation, quality accreditation or a maintenance cycle; and

· products are often designed into a specification and will typically have long life cycles.

Over the last five years to 31 May 2015 this strategy delivered 11% compound annual revenue growth and cash generated from operations of £53 million. Over the same period, the Group has invested £19 million in capital expenditure and acquisitions and turned a net debt of £14 million into a net cash position of over £6 million.

Business model outline

Our customers require filtration or emission control products that perform to a given specification; for a minimum amount of time; often with prescribed physical attributes such as size or weight. We win business by offering the best technical solutions for these requirements at an acceptable commercial cost. Filtration expertise is applicable across all markets with new products generally being adaptations of existing designs. Experience in particular markets or applications is valuable in building customer confidence. Domain knowledge is important, as is deciding where to focus resources.

This leads us to:

1. Focus on end-markets where we see long term growth potential.

2. Look for applications where product use is mandated and replacement demand is therefore regular.

3. Make new product development a core business activity.

4. Establish geographic presence where end-markets require.

5. Maintain a conservative balance sheet while re-investing in both organic and acquired growth.

Therefore:

· We focus on four end-markets: aviation; energy and industrial; environmental laboratories; and molten metals. All have clear structural growth drivers.

· Our products are specialist in nature and typically protect costly or complex downstream systems. As a result they are replaced regularly. A high proportion of our annual revenue is from repeat orders.

· We encourage new product development in order to generate growth rates in excess of the underlying market. Where possible we build robust intellectual property around our product developments. About 30% of our revenues are derived from patent protected products.

· Our geographic presence follows the markets we serve. Aviation and metals filtration revenues are strong in the Americas. In Asia, water analysis markets are growing and the demand for gasification plants is strongest.

· We aim to maintain a conservative balance sheet, meeting dividend and investment needs from free cash flow. Porvair is a cash generative business. In the last three years we have expanded manufacturing capacity in the UK, Germany, US and China and made five small acquisitions.

Operating structure

· The Group has two divisions. The Microfiltration division serves the aviation, environmental laboratory, and energy/industrial markets. The Metals Filtration division focuses on filtration of molten metals, principally aluminium.

· The Group manufactures in the UK, US, Germany and China.

Plans for investment and future development

As noted in January 2015, the Group is actively investing in capacity expansion and new product development:

· The new UK site at New Milton was formally opened in March. Old facilities have now been sold or handed back. In addition to generally upgraded facilities, the new plant offers growth capacity for industrial filters.

· The new building at Caribou, US is open. Further investment on this site is planned for the second half of 2015, notably in clean manufacturing capabilities.

· The Group is considering plans to expand its US industrial filtration facility in Virginia.

· Seal Analytical consolidated its US operations by expanding its facility in Wisconsin.

· The Metals filtration division expansion in China is proceeding on time and to budget.

· Gasification projects remain on plan. During the period, commissioning work started in the first of these in Gwangyang, South Korea. The next stage, running the plant up to operating conditions, is expected to start in the second half of 2015. Almost all systems have been shipped to Reliance for assembly on site and the first revenue has been recognised on the CNOOC project.

· New product development projects remain central to Porvair's day to day activities. A new formulation for the filtration of aluminium is testing well and patent protection is pending. Two further customers qualified the new aluminium lithium filter. Bioscience filtration projects continue to show promise.

 

Metals Filtration

 

2015

 

2014

 

Growth

 

£m

 

£m

 

%

Revenue

15.7

 

14.8

 

6

Operating profit

1.2

 

1.2

 

3

 

 

Revenue was up 6% to £15.7m (2014: £14.8m). The division is having a good year despite the strong dollar making export sales more challenging. Moreover, the prior year included a large equipment sale to a Chinese customer that, as noted at the time, will not repeat in 2015.

Despite these issues, Metals Filtration continues to build market share with its suite of patented products, and as a result revenue in constant currency is only 2% lower than in a record 2014. In two side-by-side competitive product performance tests in an aluminium customer's facilities this year, our product performance was compelling and supports the value-added sales approach that we prefer. Our rivals compete on price not performance and while this is occasionally painful, we feel it positions the business well for the longer term.

In the niche areas of metals filtration we continue to do well with unusual formulations and technical expertise. Our carbon foam products are selling steadily, as are our structured products, which are slowly developing into a higher margin line of work.

The acquisition of the trade and assets of Fiber Ceramics in June is expected to add annual revenue of around $1m to the division. More importantly, its range of products improves both the technical capability of the business in steel filtration and the production capacity for high temperature products.

Building of our second factory in China finished early in the year and manufacturing equipment is starting to be assembled. We expect to start production during the third quarter and have a new formulation with which to launch in Asia.

Microfiltration

 

2015

 

2014

 

Growth

 

£m

 

£m

 

%

Revenue

30.6

 

36.3

 

(16)

Operating profit

4.3

 

4.0

 

8

 

Revenue was £30.6m, (2014: £36.3m) with large projects contributing £8.1m less than the prior year. Underlying growth was therefore 9%, close to our five year average. A first set of patented longer life gasification spares has been shipped; coolant filtration units for the Boeing 787-9 and 787-10 are in manufacture; and new filters for both aero inerting and bioscience are in development. In the US, revenue growth has continued strongly in most markets, with our plant in Caribou performing well.

Large projects continue to be a focus. The installation in Korea is now assembled with only minor modifications required. Final acceptance testing will start, as planned, later in the year. Most shipments to the installation in India have been made, and the new project in China is in the planning and early manufacturing stage. Discussions on local operational support for these installations are progressing. Further shipments for the £11 million UK Government nuclear remediation contract are planned for the second half of the year. The pipeline of future projects is promising.

Seal Analytical sales remained level against the prior year. Throughout the period Seal Analytical's order book was at record levels but a three month parts delay from a key supplier held revenue back. The situation is now resolved and the business had a strong May and June, with July also looking promising.

Tax

The Group tax charge was £1.1 million (2014: £1.1 million). This is an effective rate of 26% (2014: 30%), in line with the rate recorded for the full year ended 30 November 2014 and higher than the UK standard corporate tax rate because tax rates are higher on profits made in Germany and the US.

 

Earnings per share and dividends

The basic earnings per share for the period increased 15% to 6.9 pence (2014: 6.0 pence). The Board is declaring an increased interim dividend of 1.3 pence (2014: 1.2 pence) per share, an increase of over 8%.

Cash flow and net debt

Cash generated from operations in the six months to 31 May 2015 was £3.1m (2014: £2.7m). Working capital increased in the period by £2.8m (2014: £3.0m) principally as a result of strong revenue in May and a high inventory of gasification spares for delivery in June.

Interest paid was £0.1m (2014: £0.2m). Tax payments reduced to £0.6m (2014: £1.2m) following a repayment in relation to 2013.

Capital expenditure was £1.4m (2014: £2.9m), mainly spent on completing the expansion of facilities in US, UK and China. £0.5m (2014: £nil) was received on the disposal of a UK facility and £0.5m (2014: £nil) was paid in relation to acquisitions completed in 2013.

Closing net cash at 31 May 2015 was £6.2m (30 November 2014: net cash of £5.3m; 31 May 2014 net debt of £1.0m).

Return on capital employed

The Group's return on capital employed was 15% (2014:13%). Excluding the impact of goodwill and the pension liability the return on operating capital employed was 47% (2014: 40%).

Current trading and outlook

Overall market demand is encouraging and order books continue to be healthy. We are winning market share with new products, notably in Metals Filtration and Seal Analytical. The Group has a strong balance sheet, a promising project pipeline and has made a good start to 2015.

 Ben Stocks

Group Chief Executive

 

 

 

Related parties

There were no related party transactions in the six months ended 31 May 2015 (2014: none).

 

Principal risks

Each division considers strategic, operational and financial risks and identifies actions to mitigate those risks. These risk profiles are reviewed by the Board and updated at least annually. The principal risks and uncertainties for the remaining six months of the financial year are discussed below. Further details of the Group's risk profile analysis can be found in the Strategic Report section of the Annual Report for the year ended 30 November 2014.

 

Certain elements of the Group's order position, although healthy at 31 May 2015, can change quickly in the face of changing economic circumstances. The Metals Filtration division and environmental laboratory supplies and general industrial filtration within the Microfiltration division all have relatively short lead times and order cycles and, therefore, revenues are subject to fluctuations, which could have a material effect on the Group's results for the balance of 2015.

 

The Microfiltration division serves several customers whose orders are large relative to Porvair's overall order book. Should any of these be cancelled or delayed it may affect the Group's results for the balance of 2015.

 

Forward looking statements

Certain statements in this half yearly financial information are forward-looking. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to have been correct. Because these statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements.

 

We undertake no obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.

 

 

 

Consolidated income statement

For the six months ended 31 May

 

 

 

Six months ended 31 May

 

 

 

2015

 

2014

 

Note

 

Unaudited

 

Unaudited

 

 

 

£'000

 

£'000

Revenue

1

 

46,261

 

51,024

Cost of sales

 

 

(30,560)

 

(36,130)

Gross profit

 

 

15,701

 

14,894

Other operating expenses

 

 

(11,218)

 

(10,699)

Operating profit

1

 

4,483

 

4,195

Interest payable and similar charges

 

 

(319)

 

(413)

Profit before income tax

 

 

4,164

 

3,782

Income tax expense

 

 

(1,062)

 

(1,149)

Profit for the period attributable to shareholders

 

 

3,102

 

2,633

 

 

 

 

 

 

Earnings per share (basic)

2

 

6.9p

 

6.0p

Earnings per share (diluted)

2

 

6.9p

 

5.9p

 

 

 

 

Consolidated statement of comprehensive income

For the six months ended 31 May

 

Six months ended 31 May

 

2015

Unaudited

 

2014

Unaudited

 

£'000

 

£'000

Profit for the period

3,102

 

2,633

Other comprehensive income:

 

 

 

Items that may be subsequently reclassified to profit or loss

 

 

 

Exchange differences on translation of foreign subsidiaries

409

 

(794)

Changes in fair value of interest rate swaps held as a cash flow hedge

-

 

20

Changes in the fair value of foreign exchange contracts held as a cash flow hedge

(160)

 

11

 

249

 

(763)

Net other comprehensive income

249

 

(763)

Total comprehensive income for the period attributable to shareholders of Porvair plc

 

3,351

 

 

1,870

 

The accompanying notes are an integral part of this interim financial information.

 

 

Consolidated balance sheet

As at 31 May

 

 

 

As at 31 May

 

As at 30 November

 

Note

2015

Unaudited

 

2014

Unaudited

 

2014

Audited

 

 

£'000

 

£'000

 

£'000

Non-current assets

 

 

 

 

 

 

Property, plant and equipment

4

12,539

 

10,865

 

12,336

Goodwill and other intangible assets

4

43,331

 

41,766

 

43,209

Deferred tax asset

 

2,900

 

3,710

 

3,240

 

 

58,770

 

56,341

 

58,785

Current assets

 

 

 

 

 

 

Inventories

 

13,060

 

12,733

 

11,363

Trade and other receivables

 

18,373

 

18,570

 

17,067

Derivative financial instruments

 

-

 

985

 

66

Cash and cash equivalents

5

8,218

 

6,428

 

7,891

 

 

39,651

 

38,716

 

36,387

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Trade and other payables

 

(25,919)

 

(24,230)

 

(24,910)

Current tax liabilities

 

(1,432)

 

(1,103)

 

(919)

Bank overdraft and loans

 

(244)

 

(984)

 

(727)

Derivative financial instruments

 

(151)

 

-

 

(118)

 

 

(27,746)

 

(26,317)

 

(26,674)

 

 

 

 

 

 

 

Net current assets

 

11,905

 

12,399

 

9,713

 

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

 

Bank loans

 

(1,794)

 

(6,440)

 

(1,900)

Deferred tax liability

 

(1,173)

 

(1,242)

 

(1,494)

Retirement benefit obligations

 

(12,732)

 

(11,787)

 

(12,833)

Other payables

 

-

 

(298)

 

-

Provisions for other liabilities and charges

 

(144)

 

(132)

 

(138)

 

 

(15,843)

 

(19,899)

 

(16,365)

Net assets

 

54,832

 

48,841

 

52,133

 

 

 

 

 

 

 

Capital and reserves

 

 

 

 

 

 

Share capital

6

896

 

883

 

887

Share premium account

6

35,344

 

35,155

 

35,334

Cumulative translation reserve

7

1,225

 

(1,103)

 

816

Retained earnings

7

17,367

 

13,906

 

15,096

Total equity

 

54,832

 

48,841

 

52,133

 

The interim financial information on pages 7 to 18 was approved by the Board of Directors on 26 June 2015 and was signed on its behalf by:

 

Ben Stocks Chris Tyler

Group Chief Executive Group Finance Director

 

The accompanying notes are an integral part of this interim financial information.

 

Consolidated cash flow statement

For the six months ended 31 May

 

 

Six months ended 31 May

 

Note

2015 Unaudited

 

2014 Unaudited

 

 

£'000

 

£'000

Cash flows from operating activities

 

 

 

 

Cash generated from operations

8

3,055

 

2,658

Interest paid

 

(91)

 

(207)

Tax paid

 

(591)

 

(1,195)

Net cash generated from operating activities

 

2,373

 

1,256

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

Acquisition of subsidiaries (net of cash acquired)

 

(490)

 

-

Purchase of property, plant and equipment

4

(1,385)

 

(2,866)

Purchase of intangible assets

4

(6)

 

(12)

Proceeds from sale of property, plant and equipment

 

475

 

9

Net cash used in investing activities

 

(1,406)

 

(2,869)

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

Net proceeds from the issue of ordinary shares

6

19

 

16

(Repayment of)/increase in borrowings

9

(637)

 

1,333

Net cash (used in)/generated from financing activities

 

(618)

 

1,349

 

 

 

 

 

Net increase/(decrease) in cash and cash equivalents

9

349

 

(264)

Effects of exchange rate changes

 

(22)

 

(81)

 

 

327

 

(345)

Cash and cash equivalents at the beginning of the period

 

7,891

 

6,773

Cash and cash equivalents at the end of the period

5

8,218

 

6,428

 

 

The accompanying notes are an integral part of this interim financial information.

 

Consolidated statement of changes in equity

For the six months ended 31 May (Unaudited)

 

 

 

Share capital

£'000

Share premium account

£'000

Cumulative translation

reserve

£'000

 

Retained earnings

£'000

 

 

Total

£'000

 

 

 

 

 

 

Balance at 1 December 2013

875

35,147

(309)

11,967

47,680

Profit for the period

-

-

-

2,633

2,633

Other comprehensive income for the period:

 

 

 

 

 

Exchange differences on translation of foreign subsidiaries

 

-

 

-

 

(794)

 

-

 

(794)

Changes in fair value of interest rate swaps held as a cash flow hedge

 

-

 

-

 

-

 

20

 

20

Changes in the fair value of foreign exchange contracts held as a cash flow hedge

 

-

 

-

 

-

 

11

 

11

Total comprehensive income for the period

-

-

(794)

2,664

1,870

Transactions with owners:

 

 

 

 

 

Proceeds from shares issued, net of costs

8

8

-

-

16

Employee share option schemes:

 

 

 

 

 

Value of employee services net of tax

-

-

-

70

70

Dividends approved as final or paid

-

-

-

(795)

(795)

Balance at 31 May 2014

883

35,155

(1,103)

13,906

48,841

 

 

 

 

 

 

Balance at 1 December 2014

887

35,334

816

15,096

52,133

Profit for the period

-

-

-

3,102

3,102

Other comprehensive income for the period:

 

 

 

 

 

Exchange differences on translation of foreign subsidiaries

 

-

 

-

 

409

 

-

 

409

Changes in the fair value of foreign exchange contracts held as a cash flow hedge

 

-

 

-

 

-

 

(160)

 

(160)

Total comprehensive income for the period

-

-

409

2,942

3,351

Transactions with owners:

 

 

 

 

 

Proceeds from shares issued, net of costs

9

10

-

-

19

Employee share option schemes:

 

 

 

 

 

Value of employee services net of tax

-

-

-

225

225

Dividends approved as final or paid

-

-

-

(896)

(896)

Balance at 31 May 2015

896

35,344

1,225

17,367

54,832

 

The accompanying notes are an integral part of this interim financial information.

 

 

Notes to the financial information

 

1. Segmental analyses

 

The chief operating decision maker has been identified as the Board of Directors. The Board of Directors review the Group's internal reporting in order to assess performance and allocate resources. Management have determined the operating segments based on this reporting.

 

As at 31 May 2015, the Group is organised on a worldwide basis into two operating segments:

1) Metals Filtration

2) Microfiltration

 

The segment results for the period ended 31 May 2015 are as follows:

 

Six months ended 31 May 2015 - Unaudited

 

Metals Filtration

 

Microfiltration

 

Other unallocated

 

Group

 

 

£'000

 

£'000

 

£'000

 

£'000

Revenue

 

15,690

 

30,571

 

-

 

46,261

 

 

 

 

 

 

 

 

 

Operating profit/(loss)

 

1,206

 

4,294

 

(1,017)

 

4,483

Interest payable and similar charges

 

-

 

-

 

(319)

 

(319)

Profit/(loss) before income tax

 

1,206

 

4,294

 

(1,336)

 

4,164

Income tax expense

 

-

 

-

 

(1,062)

 

(1,062)

Profit/(loss) for the period

 

1,206

 

4,294

 

(2,398)

 

3,102

 

The segment results for the period ended 31 May 2014 are as follows:

 

Six months ended 31 May 2014 -Unaudited

 

Metals Filtration

 

Microfiltration

 

Other unallocated

 

Group

 

 

£'000

 

£'000

 

£'000

 

£'000

Revenue

 

14,755

 

36,269

 

-

 

51,024

 

 

 

 

 

 

 

 

 

Operating profit/(loss)

 

1,166

 

3,963

 

(934)

 

4,195

Interest payable and similar charges

 

-

 

-

 

(413)

 

(413)

Profit/(loss) before income tax

 

1,166

 

3,963

 

(1,347)

 

3,782

Income tax expense

 

-

 

-

 

(1,149)

 

(1,149)

Profit/(loss) for the period

 

1,166

 

3,963

 

(2,496)

 

2,633

 

Other Group operations are included in "Other unallocated". These mainly comprise Group corporate costs, including new business development costs, some research and development costs, general financial costs, and income tax expense.

 

Segment assets and liabilities

 

At 31 May 2015 - Unaudited

 

Metals Filtration

 

Microfiltration

 

Other unallocated

 

Group

 

 

£'000

 

£'000

 

£'000

 

£'000

Segmental assets

 

28,269

 

57,791

 

4,143

 

90,203

Cash and cash equivalents

 

-

 

-

 

8,218

 

8,218

Total assets

 

28,269

 

57,791

 

12,361

 

98,421

 

 

 

 

 

 

 

 

 

Segmental liabilities

 

(3,929)

 

(20,748)

 

(4,142)

 

(28,819)

Retirement benefit obligations

 

-

 

-

 

(12,732)

 

(12,732)

Borrowings

 

-

 

-

 

(2,038)

 

(2,038)

Total liabilities

 

(3,929)

 

(20,748)

 

(18,912)

 

(43,589)

 

At 31 May 2014 - Unaudited

 

Metals Filtration

 

Microfiltration

 

Other unallocated

 

Group

 

 

£'000

 

£'000

 

£'000

 

£'000

Segmental assets

 

24,920

 

57,987

 

5,722

 

88,629

Cash and cash equivalents

 

-

 

-

 

6,428

 

6,428

Total assets

 

24,920

 

57,987

 

12,150

 

95,057

 

 

 

 

 

 

 

 

 

Segmental liabilities

 

(3,832)

 

(18,561)

 

(4,612)

 

(27,005)

Retirement benefit obligations

 

-

 

-

 

(11,787)

 

(11,787)

Borrowings

 

-

 

-

 

(7,424)

 

(7,424)

Total liabilities

 

(3,832)

 

(18,561)

 

(23,823)

 

(46,216)

 

 

 

 

 

 

 

 

 

 

At 30 November 2014 - Audited

 

Metals Filtration

 

Microfiltration

 

Other unallocated

 

Group

 

 

£'000

 

£'000

 

£'000

 

£'000

Segmental assets

 

27,119

 

55,481

 

4,681

 

87,281

Cash and cash equivalents

 

-

 

-

 

7,891

 

7,891

Total assets

 

27,119

 

55,481

 

12,572

 

95,172

 

 

 

 

 

 

 

 

 

Segmental liabilities

 

(3,249)

 

(20,379)

 

(3,951)

 

(27,579)

Retirement benefit obligations

 

-

 

-

 

(12,833)

 

(12,833)

Borrowings

 

-

 

-

 

(2,627)

 

(2,627)

Total liabilities

 

(3,249)

 

(20,379)

 

(19,411)

 

(43,039)

 

 

 

Geographical analysis

Revenue

 

Six months ended 31 May

 

2015

Unaudited

 

2014

Unaudited

 

By destination

£'000

By origin

£'000

 

By destination

£'000

By origin

£'000

United Kingdom

6,407

17,985

 

8,515

25,639

Continental Europe

6,367

3,819

 

6,339

4,014

United States of America

18,602

23,782

 

15,845

20,631

Other NAFTA

3,514

-

 

3,232

-

South America

817

-

 

834

-

Asia

10,006

675

 

15,579

740

Africa

548

-

 

680

-

 

46,261

46,261

 

51,024

51,024

 

 

2. Earnings per share

 

Six months ended 31 May

 

 

2015

Unaudited

 

2014

Unaudited

 

 

 

 

 

 

 

 

 

 

 

Earnings

 

 

£'000

Weighted average number of shares

Per share amount

 

Pence

 

Earnings

 

 

£'000

Weighted average number of shares

Per share amount

 

Pence

Basic EPS - Earnings attributable to ordinary shareholders

 

 

3,102

 

 

44,659,379

 

 

6.9

 

 

 

2,633

 

 

44,017,345

 

 

6.0

Effect of dilutive securities - share options

 

-

 

146,675

 

-

 

 

-

 

283,053

 

(0.1)

Diluted EPS

3,102

44,806,054

6.9

 

2,633

44,300,398

5.9

         

 

 

3. Dividends per share

 

Six months ended 31 May

 

2015

 

2014

 

Unaudited

 

Unaudited

 

Per share

£'000

 

Per share

£'000

Final dividend approved

2.00p

896

 

1.80p

795

 

The final dividend approved was paid to shareholders on 6 June 2015.

 

The Directors have declared an interim dividend of 1.3 pence (2014: 1.2 pence) per share to be paid on 4 September 2015 to shareholders on the register at the close of business on 31 July 2015. The ex-dividend date for the shares is 30 July 2015.

 

 

4. Property, plant and equipment and goodwill and other intangible assets

 

Six months ended 31 May 2015 - Unaudited

 

Property, plant and equipment

 

Goodwill and other intangible assets

 

Total

 

 

£'000

 

£'000

 

£'000

Opening net book amount at 1 December 2014

 

12,336

 

43,209

 

55,545

Additions

 

1,385

 

6

 

1,391

Disposals

 

(397)

 

-

 

(397)

Depreciation and amortisation

 

(912)

 

(182)

 

(1,094)

Exchange movements

 

127

 

298

 

425

Closing net book amount at 31 May 2015

 

12,539

 

43,331

 

55,870

 

 

Six months ended 31 May 2014 - Unaudited

 

Property, plant and equipment

 

Goodwill and other intangible assets

 

Total

 

 

£'000

 

£'000

 

£'000

Opening net book amount at 1 December 2013

 

9,006

 

42,535

 

51,541

Additions

 

2,866

 

12

 

2,878

Disposals

 

(18)

 

-

 

(18)

Depreciation and amortisation

 

(849)

 

(177)

 

(1,026)

Exchange movements

 

(140)

 

(604)

 

(744)

Closing net book amount at 31 May 2014

 

10,865

 

41,766

 

52,631

 

5. Cash and cash equivalents

 

 

As at 31 May

 

As at 30 November

 

2015

Unaudited

£'000

 

2014

Unaudited

£'000

 

2014

Audited

£'000

Cash at bank and in hand

8,218

 

6,428

 

7,891

Cash and cash equivalents

8,218

 

6,428

 

7,891

 

 

6. Share capital and premium

 

 

Number of shares (thousands)

 

Ordinary shares

Unaudited

 

Share premium account

Unaudited

 

 

Total

Unaudited

 

 

 

 

£'000

 

£'000

 

£'000

At 1 December 2013

 

43,734

 

875

 

35,147

 

36,022

Employee share options schemes:

 

 

 

 

 

 

 

 

Exercise of options under share option schemes

 

 

433

 

 

8

 

 

8

 

 

16

At 31 May 2014

 

44,167

 

883

 

35,155

 

36,038

 

 

 

 

 

 

 

 

 

At 1 December 2014

 

44,363

 

887

 

35,334

 

36,221

Employee share options schemes:

 

 

 

 

 

 

 

 

Exercise of options under share option schemes

 

 

450

 

 

9

 

 

10

 

 

19

At 31 May 2015

 

44,813

 

896

 

35,344

 

36,240

 

 

 

 

 

 

 

 

 

 

The authorised number of ordinary shares is 75 million (2014: 75 million) shares with a par value of 2.0 pence (2014: 2.0 pence) per share. All issued shares are fully paid. 450,221 (2014: 433,345) ordinary shares of 2p each were issued in the period on the exercise of employee share options for a cash consideration of £19,000 (2014: £16,000).

 

 

7. Other reserves

 

 

 

Cumulative translation reserve

Unaudited

 

 

Retained earnings

Unaudited

 

 

 

£'000

 

£'000

At 1 December 2013

 

 

(309)

 

11,967

Profit for the period attributable to shareholders

 

 

-

 

2,633

Direct to equity:

 

 

 

 

 

Final dividends approved

 

 

-

 

(795)

Share based payments

 

 

-

 

238

Tax on share based payments

 

 

-

 

(168)

Interest rate swap cash flow hedge

 

 

-

 

20

Foreign exchange contract cash flow hedge

 

 

-

 

11

Exchange differences

 

 

(794)

 

-

At 31 May 2014

 

 

(1,103)

 

13,906

 

 

 

 

 

 

At 1 December 2014

 

 

816

 

15,096

Profit for the period attributable to shareholders

 

 

-

 

3,102

Direct to equity:

 

 

 

 

 

Final dividends approved

 

 

-

 

(896)

Share based payments

 

 

-

 

238

Tax on share based payments

 

 

-

 

(13)

Foreign exchange contract cash flow hedge

 

 

-

 

(160)

Exchange differences

 

 

409

 

-

At 31 May 2015

 

 

1,225

 

17,367

 

 

 

 

 

 

 

8. Cash generated from operations

 

 

Six months ended 31 May

 

 

2015

Unaudited

£000

 

2014

Unaudited

£000

Operating profit

 

4,483

 

4,195

Non-cash pension charge

 

166

 

120

Share based payments

 

238

 

238

Depreciation and amortisation

 

1,094

 

1,026

(Profit)/loss on disposal of property, plant and equipment

 

(78)

 

9

Operating cash flows before movement in working capital

 

5,903

 

5,588

Increase in inventories

 

(1,694)

 

(1,273)

Increase in trade and other receivables

 

(1,338)

 

(4,558)

Increase in payables

 

184

 

2,901

Increase in working capital

 

(2,848)

 

(2,930)

Cash generated from operations

 

3,055

 

2,658

 

 

9. Reconciliation of net cash flow to movement in net debt

 

Six months ended 31 May

 

2015

Unaudited

£'000

 

2014

Unaudited

£'000

Net increase/(decrease) in cash and cash equivalents

349

 

(264)

Effects of exchange rate changes

(70)

 

22

Repayment of / (increase in) borrowings

637

 

(1,333)

Net cash at the beginning of the period

5,264

 

579

Net cash/(debt) at the end of the period

6,180

 

(996)

 

10. Financial risk management and financial instruments

 

The Group's finance department includes a team that performs the valuations of financial assets and liabilities required for financial reporting purposes, including Level 3 fair values. This team reports directly to the Group Finance Director and the Audit Committee. Discussions of valuation processes and results are held between the Group Finance Director, the Audit Committee and the valuation team at least twice a year, in line with the Group's external reporting dates.

 

The table below analyses financial instruments carried at fair value, by valuation method. The different levels have been defined below:

 

· Quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1).

· Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices) (Level 2).

· Inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs) (Level 3).

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

£'000

 

£'000

 

£'000

 

£'000

 

Financial assets and (liabilities) at fair value through profit or loss:

- Trading derivatives

 

 

 

-

 

 

 

(57)

 

 

 

-

 

 

 

(57)

Deferred and contingent consideration

 

-

 

-

 

(328)

 

(328)

Foreign exchange contracts used for hedging

 

-

 

(94)

 

-

 

(94)

At 31 May 2015

 

-

 

(151)

 

(328)

 

(479)

 

 

 

 

 

 

 

 

 

Financial assets and (liabilities) at fair value through profit or loss:

- Trading derivatives

 

 

 

-

 

 

 

(118)

 

 

 

-

 

 

 

(118)

Deferred and contingent consideration

 

-

 

-

 

(924)

 

(924)

Foreign exchange contracts used for hedging

 

-

 

66

 

-

 

66

At 30 November 2014

 

-

 

(52)

 

(924)

 

(976)

 

 

 

 

 

 

 

 

 

 

There were no transfers between levels during the period, and there were no changes in valuation techniques in the period.

 

11. Post balance sheet event - Acquisition

Agreement has been reached to acquire the goodwill, business and trading assets of Fiber Ceramics, Inc on 29 June 2015. This small acquisition provides filtration products for steel foundry applications.

 

12. Exchange rates

Exchange rates for the US dollar during the period were:

 

Average rate to 31 May 15

Average rate to 31 May 14

Closing rate at 31 May 15

Closing rate at 30 Nov 14

 

Unaudited

Unaudited

Unaudited

Unaudited

US dollar

1.53

1.66

1.53

1.57

 

13. Seasonality

The results for the six months ended 31 May 2015 are impacted by a lower number of working days in the first six months of the year than in the second half of the year.

 

14. Basis of preparation

Porvair plc is a public limited company registered in the UK and listed on the London Stock Exchange.

 

This unaudited condensed half-yearly consolidated financial information for the six months ended 31 May 2015 has been prepared in accordance with the Disclosure and Transparency Rules ('DTR') of the Financial Conduct Authority and with IAS 34, 'Interim financial reporting' as adopted by the European Union. The condensed half-yearly consolidated financial information should be read in conjunction with the annual financial statements for the year ended 30 November 2014, which were approved by the Board of Directors on 23 January 2015 and which have been prepared in accordance with IFRSs as adopted by the European Union.

 

The accounting policies adopted are consistent with those of the annual financial statements for the year ended 30 November 2014, as described in those financial statements.

 

Taxes on income in the interim period are accrued using the tax rate that would be applicable to expected total annual earnings.

 

This condensed half-yearly consolidated financial information has been prepared on a going concern basis under the historical cost convention, as modified by the revaluation of certain current assets, financial assets and financial liabilities held for trading and derivative contracts, which are held at fair value.

 

The preparation of condensed half-yearly consolidated financial information in conformity with generally accepted accounting principles requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed half-yearly consolidated financial information and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on management's best knowledge of the amount, event or actions, actual results may ultimately differ from those estimates.

 

After having made appropriate enquiries, including a review of progress against the Group's budget for 2015, its medium term plans and taking into account the banking facilities available until January 2018, the Directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing this condensed half-yearly consolidated financial information.

 

This condensed half-yearly consolidated financial information and the comparative figures does not constitute full accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 30 November 2014, which include an unqualified audit report, no emphasis of matter paragraph and no statements under sections 498(2) or (3) of the Companies Act 2006, have been delivered to the Registrar of Companies.

 

The condensed half-yearly consolidated financial information does not include all financial risk management information and disclosures required in the annual financial statements; it should be read in conjunction with the Group's annual financial statements for the year ended 30 November 2014. There have been no changes in any risk management policies since the year end.

 

This report will be available at Porvair plc's registered office at 7 Regis Place, Bergen Way, King's Lynn, PE30 2JN and on the Company's website www.porvair.com.

 

 

 

Statement of directors' responsibilities

 

The Directors confirm that this condensed half-yearly consolidated financial information has been prepared in accordance with IAS 34 as adopted by the European Union and that the interim management report herein includes a fair review of the information required by DTR 4.2.7 and DTR 4.2.8, namely:

§ an indication of important events that have occurred during the first six months of the year, their impact on the condensed half-yearly consolidated financial information and a description of the principal risks and uncertainties for the remaining six months of the financial year; and

§ material related party transactions in the first six months of the year and any material changes in the related party transactions described in the last annual report.

 

The Directors of Porvair plc are listed in the Porvair plc Annual Report for the year ended 30 November 2014. A list of current Directors is maintained on the Porvair plc website www.porvair.com.

 

By order of the board

 

 

 

 

Ben Stocks

Group Chief Executive

 

 

 

 

Chris Tyler

Group Finance Director

 

26 June 2015

 

 

 

Independent review report to Porvair plc

Report on the condensed half-yearly consolidated financial information

Our conclusion

We have reviewed the condensed half-yearly consolidated financial information defined below, in the half-yearly results of Porvair plc for the six months ended 31 May 2015. Based on our review, nothing has come to our attention that causes us to believe that the condensed half-yearly consolidated financial information is not prepared, in all material respects, in accordance with International Accounting Standard 34 as adopted by the European Union and the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority.

This conclusion is to be read in the context of what we say in the remainder of this report.

What we have reviewed

The condensed half-yearly consolidated financial information which is prepared by Porvair plc comprises:

· the consolidated balance sheet as at 31 May 2015;

· the consolidated income statement and consolidated statement of comprehensive income for the period then ended;

· the consolidated statement of cash flows for the period then ended;

· the consolidated statement of changes in equity for the period then ended; and

· the explanatory notes to the condensed half-yearly consolidated financial information.

As disclosed in note 14, the financial reporting framework that has been applied in the preparation of the full annual financial statements of the group is applicable law and International Financial Reporting Standards (IFRSs) as adopted by the European Union.

The condensed half-yearly consolidated financial information included in the half-yearly results have been prepared in accordance with International Accounting Standard 34, 'Interim Financial Reporting', as adopted by the European Union and the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority.

What a review of condensed half-yearly consolidated financial information involves

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures.

A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and, consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

We have read the other information contained in the half-yearly results and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed half-yearly consolidated financial information.

 

Responsibilities for the condensed half-yearly consolidated financial information and the review

Our responsibilities and those of the directors

The half-yearly results, including the condensed half-yearly consolidated financial information, is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly results in accordance with the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority.

Our responsibility is to express to the company a conclusion on the condensed half-yearly consolidated financial information in the half-yearly results based on our review. This report, including the conclusion, has been prepared for and only for the company for the purpose of complying with the Disclosure and Transparency Rules of the Financial Conduct Authority and for no other purpose. We do not, in giving this conclusion, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.

PricewaterhouseCoopers LLP

Chartered Accountants

26 June 2015

Cambridge

 

Notes

 

(a) The maintenance and integrity of the Porvair plc website is the responsibility of the directors; the work carried out by the auditors does not involve consideration of these matters and, accordingly, the auditors accept no responsibility for any changes that may have occurred to the condensed half-yearly consolidated financial information since it was initially presented on the website.

(b) Legislation in the United Kingdom governing the preparation and dissemination of condensed half-yearly consolidated financial information may differ from legislation in other jurisdictions.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR BLGDLGGDBGUI
Date   Source Headline
23rd Apr 20241:38 pmRNSDirector/PDMR Shareholding
16th Apr 20242:56 pmRNSAGM Results Announcement
16th Apr 20247:00 amRNSAGM Trading Update & Board Update
3rd Apr 20247:00 amRNSDirector resignation
12th Mar 20247:00 amRNSDirector declaration
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20244:41 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSResults for the year ended 30 November 2023
1st Feb 20247:00 amRNSBlock listing Interim Review
19th Dec 202310:25 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSTrading Update & Acquisition
4th Dec 202312:00 pmRNSHolding(s) in Company
25th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSNine Month Trading Update
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSAcquisition completion
7th Jul 20234:00 pmRNSBlock Listing Application
3rd Jul 20237:00 amRNSInterim Results
26th Jun 20237:00 amRNSBoard Change
21st Jun 20234:22 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSBlock listing Interim Review
4th May 20237:00 amRNSAcquisitions
18th Apr 202312:51 pmRNSAGM resolutions
18th Apr 20237:00 amRNSAGM Trading Update
31st Mar 20234:00 pmRNSTotal Voting Rights
22nd Mar 20233:03 pmRNSGrant of options
1st Mar 20239:30 amRNSTotal Voting Rights
2nd Feb 20235:42 pmRNSGrant of LTSP awards
30th Jan 20237:00 amRNSResults for the year ended 30 November 2022
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSTrading Update, Notice of Results and Board Change
1st Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 202210:00 amRNSTotal Voting Rights
29th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20224:00 pmRNSBlock listing Interim Review
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20229:30 amRNSDirector declaration and resignation
12th Oct 20224:26 pmRNSDirector/PDMR Shareholding
5th Oct 20225:30 pmRNSHolding(s) in Company
5th Oct 20225:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSTrading Update-Ahead of Expectations
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension
13th Sep 20227:00 amRNSNine Month Trading Update
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.